Episode Details
Back to EpisodesPrad Sekar on Leveraging Data to Bring Medical Cannabis to the Masses | #HashtagFinance
Description
CB2 Insight's (CSE:CBII) CEO Pradyum Sekar recently sat down with Barrington Miller to discuss the importance of medically validated cannabis data (3:45), the challenge of breaking down barriers with physicians (9:45), and the impact of big pharma on medical cannabis (13:30). Listen until the end to hear about Prad's experience around launching the company, pivoting the business (hint - vertical integration!), and their recent launch on the CSE - Canadian Securities Exchange.
🔴 Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe
#AlwaysInvested
STAY CONNECTED WITH THE CSE
=============================
📧 - NEWSLETTER: https://go.thecse.com/CSE-Mailing-List-Subscribe
🎧 - PODCAST: https://blog.thecse.com/cse-podcasts/
📸 - INSTAGRAM: https://www.instagram.com/canadianexchange/
🤝 - LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
👥 - FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
🐦 - X: https://x.com/CSE_News
📝 - BLOG: https://blog.thecse.com/
🖥 - WEBSITE: https://thecse.com/
📖 - MAGAZINE: https://issuu.com/thecse/docs
©2026 CNSX Markets Inc. All rights reserved.